title: Conversion to triple therapy in renal allograft patients with renal dysfunction and chronic interstitial lesions or vascular lesions on renal biopsy.
authors.affiliation: Department of Renal Medicine, St. Philip's Hospital, London, England.
authors.forename: B
authors.initials: B
authors.lastname: Leaker
authors.forename: G H
authors.initials: GH
authors.lastname: Neild
authors.forename: C
authors.initials: C
authors.lastname: Rudge
authors.forename: M
authors.initials: M
authors.lastname: Mansell
authors.forename: F D
authors.initials: FD
authors.lastname: Thompson
mesh_terms: D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use*; D001706:Biopsy; D002986:Clinical Trials as Topic; D003524:Cyclosporins / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006084:Graft Rejection; D006801:Humans; D007668:Kidney / Q000473:pathology / Q000503:physiopathology; D016030:Kidney Transplantation; D011239:Prednisolone / Q000627:therapeutic use*; D014184:Transplantation, Homologous
chemical_list: D000961:Antilymphocyte Serum; D003524:Cyclosporins; D011239:Prednisolone; D001379:Azathioprine